News
COMBINE will support the coordination of the Innovative Medicines Initiative (IMI) Antimicrobial Resistance (AMR) Accelerator Programme…
For the first time, scientists from Jena succeeded to cultivate and functionally characterize a total of…
A new EU report sees only slow progress in the fight against AMR. The BEAM Alliance…
A drug combo breaking antibiotic resistance of Gram-negative priority pathogens has been selected under the ENABLE…
Despite challenging markets new players are entering the field to advance drug development in the fight…
Antibiotic developers struggle with uncertain market conditions, weak reimbursement schemes and low turnover once a drug…
Swiss biotech company BioVersys AG has received a €8m grant by US-based non-profit organisation CARB-X to…
Swiss Polyphor AG and researchers from the University of Zurich have presented the mechanism of action…
In 2019, a new AMR accelerator kicked off under the aegis of the Innovative Medicines Initiative…
UK–based biotech company Procarta Biosystems has been funded by CARB-X to develop a new class of…
India has joined the Global AMR R&D Hub as a new Member. This expands the global…
Swiss researchers from Zurich and Basel have discovered that resistance in intestinal bacteria can spread even…
WHO has published target product profiles for diagnostics against antibacterial resistance identified as priorities. Until 29th…
Erin Duffy, former CSO of US biotech company Melinta Therapeutics, replaces Karen Gallant as CARB-X‘s Chief…
To help guide the Global AMR R&D Hub’s collaborations a draft Collaboration Framework has been developed.…
CARB-X has recently funded several vaccines projects to fight AMR-related infections developed by US-based SutroVax and…
The WHO has developed several draft target products profiles (TPPs) and is seeking feedback from AMR…
Nabriva Therapeutics plc has got the go from the FDA to market its pleuromutilin antibiotic Xenleta…
Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel…
The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma company Shionogi…
HHS’s Biomedical Advanced Research and Development Authority, or BARDA, will provide up to $20.7 million over…
Today, the Novo Holdings REPAIR Impact Fund announced a USD 5.25 million investment in Curza, a…
A new collaboration aims to the urgent fight against antimicrobial resistant bacteria. Lyon-headquartered biotech Nosopharm has…
FIND signs US$14.5 million grant with Unitaid to evaluate next-generation sequencing for rapid, affordable diagnosis of…
GARDP has calls up the global community to develop five new treatments that break antimicrobial resistance…
BioVersys has been awarded EUR 6.92 Million funding for TRIC-TB from the Innovative Medicines Initiative 2…
In late April, CARB-X announced its 2019 rounds of funding to support the development of antibiotics,…
The REPAIR Impact Fund has opened its second investment proposal round to European life science companies…
BEAM Alliance has released a new position paper on PUSH Incentives called ‘Supporting financial investments on…
The AMR Centre has received £2.3 million to support the expansion of its pipeline of new…
Bacteria may travel thousands of miles through the air worldwide instead of hitching rides with people…
More than 330 experts joined the 2-day AMR Conference 2019 in Berlin. They called for rapid…
More than 330 international experts will come together in Berlin to discuss the most pressing challenges…
We spoke with Kevin Outterson, Executive Director of CARB-X and speaker at AMR Conference 2019, about…
CARB-X has expanded its reach by adding six partners from Germany, Switzerland, Denmark and India to…
In Mid-February, the UKRI Cross-Council AMR Initiative hosted a parliamentary panel highlighted the importance of research…
German stakeholders Evotec AG and the Helmholtz Centre for Infection Research (HZI) have joined platforms in…
US researchers have shown that insect-associated microbes provide their hosts with protection against infections, suggesting that…
According to the newly published JPI AMR Research Funding Dashboard, the 22 member countries invested around…
US stakeholders active in AMR have sent a letter to US congress representatives urging the need…
CARB-X funds US-company Recida Therapeutics to accelerate further development of the LpxC program to treat gram-negative…
NIAID is updating its antimicrobial resistance program and is seeking public input into strategic approaches. In…
CARB-X is providing funding for the further development of Polyphor’s new class of Outer Membrane Protein…
The British start-up Amprologix secured government funding to make its epidermicin NI01 antibiotic ready for the…
The executive board of the WHO’s World Health Assembly has agreed on a draft solution on…
The UN IACG has now released its draft recommendations. Until Februar 19, all stakeholders are invited…
British researchers have discovered the antibiotic-resistant gene NDM-1 in arctic soils, far away of human presence.…
The World Health Organization has published a first call to establish a pre-clinical pipeline overview in…
In order to incentivise drug companies to re-enter development of antibiotics, the UK government announced it…
FDA has finalized its guidance on how to coordinate development of antimicrobials and ASTs. In February,…
US agency BARDA is pushing forward its DRIVe Venture initiative. It now seeks feedback on this…
Novo Holdings has invested €18m from its €135m REPAIR Impact Fund into four companies and appointed…
EMA has published a revised guideline that aims to strengthen the development of new antibacterial medicines.…
The World Health Organization has published the ten threats to global health that merit special attention…
The Centers for Disease Control and Prevention (CDC) are working towards an update of their Antimicrobial…
A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found…
During the Grand Challenges meeting of Bill and Melinda Gates Foundation in October 2018, there was…
In China, two new bacteria species have been found in patients’s blood. They were found during…
An article in Forbes explores, why more startups in animal health should develop novel antibiotics and…
Researchers of Sichuan University, China, report that they have discovered two new species of resistant bacteria…
Curetis’ subsidiary Ares Genetics advances AI-powered antibiotic resistance test within a new project co-funded by Vienna…
The US Centers for Disease Control & Prevention (CDC) has awarded more than US$15m for innovative…
The French and German research ministries are launching their first joint call for projects on antimicrobial…
Forge Therapeutics, Inc., a biotechnology company developing novel medicines targeting metalloenzymes, announced that it has received…
Novartis is donating data from its abandoned antibiotic research programmes on Pew’s open-access SPARK. Launched in…